脳体部オキシメータの世界市場：製品タイプ別、用途別、技術別、地域範囲別、予測

脳体部オキシメータの市場規模と予測

脳体部オキシメータの世界市場規模は、2024年に2億6,267万米ドルと評価され、2026年から2032年にかけてCAGR 7.50%で成長し、2032年には4億4,457万米ドルに達すると予測されています。

脳体部オキシメータは、脳組織の酸素濃度を測定し、脳酸素化と血流に関する貴重な情報を提供する医療機器です。

低酸素症や脳虚血のような潜在的な問題を検出するため、主に手術、集中治療、神経学的検査中の患者の監視と管理に使用されます。

脳体部オキシメータの将来には、非侵襲的モニタリング技術の進歩、より広範な健康モニタリングシステムとの統合、様々な臨床現場での使用拡大が含まれ、これらはすべて継続的な技術革新と正確な脳健康モニタリングへの需要の高まりによって推進されます。

脳体部オキシメータの世界市場力学

脳体部オキシメータの世界市場を形成している主な市場力学は以下の通り：

主な市場促進要因

神経疾患の有病率の増加：脳卒中や脳損傷などの神経疾患の有病率の増加が、脳体細胞オキシメータの需要を押し上げています。メドトロニックは2024年6月、脳モニタリングソリューションの製品レンジを拡大し、ヘルスケア需要の増加に対応しました。

モニタリング機器の技術開発：センサーの改良やリアルタイムのデータ解析といったオキシメトリー技術の進歩は、脳体部オキシメーターの精度と機能を向上させる。例えば、2024年7月、Nonin Medical社は、信号処理能力を向上させた新しい先進脳オキシメータを発表しました。

患者の安全性とモニタリングの重視の高まり。手術やクリティカルケアにおける患者の安全性と継続的なモニタリングがより重視されるようになっています。2024年4月、米国食品医薬品局（FDA）は新しい脳内酸素濃度計を承認し、高度なモニタリング技術に対する規制当局の支持が高まっていることが示されました。

ヘルスケア施設の拡大と投資：医療インフラの拡大や高度診断ツールへの投資が市場成長の原動力となっています。フィリップスヘルスケアは2024年3月、病院や手術センターでの需要増に対応するため、脳内オキシメトリ製品ラインを拡充する大規模投資を発表しました。

主な課題

先進デバイスの高コスト：先進的な脳体部オキシメータの高価格は、特にリソースの少ない医療環境では、導入の大きな障壁となりうる。このような機器は高価であるため、最先端技術へのアクセスが制限されることが多いです。

精度と校正のばらつき：脳オキシメータの精度のばらつきは、校正やセンサー技術の違いにより問題となることがあります。複数の装置や患者の状態にわたって一貫した信頼できる測定値を維持することは、依然として最優先事項です。

既存システムとの統合の複雑さ：脳体部オキシメータを現行の医療モニタリングシステムに統合することは困難であり、インフラの追加変更が必要になる場合があります。この統合プロセスはヘルスケア施設にとって困難で時間がかかります。

限られた認識とトレーニング：ヘルスケア専門家は、脳体部オキシメータの適切な使用方法についての認識やトレーニングが不足していることが多いです。その結果、非効率的な使用となり、患者ケアにおける装置の潜在的な利点が過小評価される可能性があります。

主な動向

高度モニタリングシステムの統合：脳体部オキシメータを麻酔装置やクリティカルケア装置などの他の高度モニタリングシステムと組み合わせる傾向が高まっています。この統合により、包括的な患者モニタリングとリアルタイムのデータ分析が強化され、臨床転帰が改善されます。

ウェアラブル・ポータブルデバイスの開発：ウェアラブルで携帯可能な脳オキシメーターは、従来の病院環境以外でも継続的で便利なモニタリングを可能にし、ますます普及してきています。

非侵襲的技術の進歩：技術の進歩は非侵襲的測定技術の向上を目指しており、その結果、より正確で信頼性の高い脳酸素濃度データが得られるようになりました。最近の進歩には、高度なセンサー技術や信号処理アルゴリズムの改良が含まれます。

さまざまな臨床現場での利用の拡大：脳体部酸素濃度計は、循環器科や産科など、脳神経外科以外の臨床現場でも使用されるようになってきています。さまざまな医療分野でこれらの機器が使用されていることは、さまざまな患者の状態における脳酸素レベルのモニタリングにおいて、その有用性が高まっていることを示しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 脳体部オキシメータ市場：製品タイプ別

• 非侵襲性脳体部オキシメータ
• 侵襲性脳体部オキシメータ

第5章 脳体部オキシメータ市場：用途別

• 神経クリティカルケア
• 麻酔学
• 新生児医療
• 循環器科
• スポーツ医学

第6章 脳体部オキシメータ市場：技術別

• 近赤外分光法（NIRS）
• 光音響分光法（PAS）
• 拡散相関分光法（DCS）

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Masimo
• Medtronic
• Edwards Lifesciences
• ISS Inc.
• Nonin Medical, Inc.
• Koninklijke Philips N.V.
• Mespere LifeSciences
• GE Healthcare

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Cerebral Somatic Oximeters Market Size And Forecast

Global Cerebral Somatic Oximeters Market size was valued at USD 262.67 Million in 2024 and is projected to reach USD 444.57 Million by 2032, growing at a CAGR of 7.50% from 2026 to 2032.

Cerebral somatic oximeters are medical devices that measure oxygen levels in brain tissues, providing valuable information about cerebral oxygenation and blood flow.

They are primarily used to monitor and manage patients during surgeries, intensive care, and neurological examinations in order to detect potential problems such as hypoxia or brain ischemia.

The future of cerebral somatic oximeters includes advancements in non-invasive monitoring technologies, integration with broader health monitoring systems, and expanded use in a variety of clinical settings, all driven by ongoing innovation and the growing demand for precise cerebral health monitoring.

Global Cerebral Somatic Oximeters Market Dynamics

The key market dynamics that are shaping the global cerebral somatic oximeters market include:

Key Market Drivers:

Increasing Prevalence of Neurological Disorders: The growing prevalence of neurological disorders, such as stroke and brain injuries, is driving up demand for cerebral somatic oximeters. Medtronic expanded its range of cerebral monitoring solutions in June 2024 to meet the growing healthcare demand.

Technological Developments in Monitoring Devices: Oximetry technology advancements, such as improved sensors and real-time data analysis, improve the accuracy and functionality of cerebral somatic oximeters. For example, in July 2024, Nonin Medical unveiled a new advanced cerebral oximeter with improved signal processing capabilities.

Growing Emphasis on Patient Safety and Monitoring: There is a greater emphasis on patient safety and continuous monitoring during surgeries and critical care. In April 2024, the US Food and Drug Administration (FDA) approved a new cerebral oximeter device, demonstrating increased regulatory support for advanced monitoring technologies.

Expansion of Healthcare Facilities and Investments: The expansion of healthcare infrastructure, as well as investments in advanced diagnostic tools, are driving market growth. Philips Healthcare announced a significant investment in March 2024 to expand its cerebral oximetry product line in response to increasing demand in hospitals and surgical centers.

Key Challenges:

High Cost of Advanced Devices: The high cost of advanced cerebral somatic oximeters can be a significant barrier to adoption, particularly in low-resource healthcare settings. Access to cutting-edge technologies is frequently limited due to the high cost of such equipment.

Variability in Accuracy and Calibration: Variability in cerebral oximeter accuracy can be problematic due to differences in calibration and sensor technology. Maintaining consistent and reliable readings across multiple devices and patient conditions remains a top priority.

Complexity of Integration with Existing Systems: Integrating cerebral somatic oximeters with current medical monitoring systems can be difficult and may necessitate additional infrastructure changes. This integration process can be difficult and time-consuming for healthcare facilities.

Limited Awareness and Training: Healthcare professionals frequently lack awareness and training on how to use cerebral somatic oximeters properly. This can result in inefficient use and underestimation of the device's potential benefits in patient care.

Key Trends:

Integration of Advanced Monitoring Systems: There is an increasing trend of combining cerebral somatic oximeters with other advanced monitoring systems, such as anesthesia and critical care equipment. This integration enhances comprehensive patient monitoring and real-time data analysis, resulting in better clinical outcomes.

Development of Wearable and Portable Devices: Wearable and portable cerebral oximeters are becoming increasingly popular, allowing for continuous and convenient monitoring outside of traditional hospital settings.

Advancements in Non-invasive Technologies: Technological advancements are aimed at improving non-invasive measurement techniques, resulting in more accurate and reliable cerebral oxygenation data. Recent advancements include advanced sensor technologies and improved signal processing algorithms.

Growing Use in Various Clinical Settings: Cerebral somatic oximeters are increasingly used in clinical settings other than neurosurgery, such as cardiology and obstetrics. The use of these devices in various medical fields demonstrates their growing utility in monitoring cerebral oxygen levels in a variety of patient conditions.

Global Cerebral Somatic Oximeters Market Regional Analysis

Here is a more detailed regional analysis of the global cerebral somatic oximeters market:

North America:

North America is emerging as the dominant force in the cerebral somatic oximeters market, owing to advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and significant R&D investments. The United States, in particular, dominates this market due to its large number of well-equipped hospitals, strict patient safety regulations, and high prevalence of cardiovascular and neurological disorders.

The region's dominance is reinforced by the presence of major market players such as Medtronic, Edwards Lifesciences, and Nonin Medical, which are constantly innovating and improving their cerebral oximetry technology. Furthermore, the growing emphasis on reducing perioperative complications and improving patient outcomes in surgical and critical care settings has accelerated the adoption of these devices in North American healthcare facilities.

In February 2024, Medtronic unveiled its next-generation cerebral somatic oximeter which includes artificial intelligence to provide more accurate tissue oxygenation monitoring during complex surgeries. This launch is expected to strengthen Medtronic's market position and accelerate adoption rates in North American hospitals. In April 2024, the United States Food and Drug Administration (FDA) issued new guidelines for the use of cerebral oximetry in pediatric cardiac surgeries, emphasizing the importance of continuous cerebral monitoring in high-risk procedures. This regulatory update is expected to increase demand for cerebral somatic oximeters in pediatric care units across the United States, thereby expanding the market in North America.

Asia Pacific:

The Asia Pacific region is projected to witness fastest growth in the cerebral somatic oximeters, owing to increased awareness of patient monitoring during surgeries, rising healthcare costs, and growing adoption of advanced medical technologies. Countries such as China, Japan, India, and South Korea are at the forefront of this expansion, with large populations and rapidly developing healthcare infrastructures driving significant demand for these devices. The region's emphasis on improving patient outcomes, particularly in critical care and surgical settings, has resulted in an increase in the use of cerebral oximeter technology. Furthermore, the rising prevalence of cardiovascular and neurological disorders among Asia's aging populations has increasing demand for these monitoring devices.

In March 2024, Masimo Corporation, a global leader in noninvasive monitoring technologies, announced that it would expand its manufacturing facilities in Malaysia to meet Asia Pacific's growing demand for cerebral oximeters. This move is expected to significantly boost the availability of these devices in the region. In January 2024, the Chinese National Health Commission announced a new five-year plan to improve perioperative patient safety, which includes significant investments in advanced monitoring technologies such as cerebral somatic oximeters. This initiative is expected to increase the adoption of these devices in Chinese hospitals, accelerating market growth in the Asia Pacific region.

Global Cerebral Somatic Oximeters Market: Segmentation Analysis

The Global Cerebral Somatic Oximeters Market is segmented on the basis of By Product Type, By Application, By Technology and Geography.

Global Cerebral Somatic Oximeters Market, By Product Type

• Non-invasive Cerebral Somatic Oximeters
• Invasive Cerebral Somatic Oximeters

Based on Product Type, the Global Cerebral Somatic Oximeters Market is segmented into Non-invasive Cerebral Somatic Oximeters and Invasive Cerebral Somatic Oximeters. Non-invasive cerebral somatic oximeters are popular due to their widespread use and preference for monitoring without the need for surgical procedures, resulting in ease of use and patient comfort. The invasive cerebral somatic oximeters segment is the fastest growing, driven by rising demand for precise and direct measurements in complex and high-risk medical procedures where accuracy is critical.

Global Cerebral Somatic Oximeters Market, By Application

• Neurocritical Care
• Anesthesiology
• Neonatal Care
• Cardiology
• Sports Medicine

Based on Application, the Global Cerebral Somatic Oximeters Market is segmented into Neurocritical Care, Anesthesiology, Neonatal Care, Cardiology, and Sports Medicine. The neurocritical care segment is dominant because it plays an important role in monitoring cerebral oxygenation in patients with severe neurological conditions and during complex surgeries. The neonatal care segment is expanding at the fastest rate, owing to increased awareness of the importance of monitoring cerebral oxygen levels in newborns and advances in neonatal care technology.

Global Cerebral Somatic Oximeters Market, By Technology

• Near-infrared spectroscopy (NIRS)
• Photoacoustic spectroscopy (PAS)
• Diffuse correlation spectroscopy (DCS)

Based on Technology, the Global Cerebral Somatic Oximeters Market is segmented into Near-infrared spectroscopy (NIRS), Photoacoustic spectroscopy (PAS), Diffuse correlation spectroscopy (DCS). Near-infrared spectroscopy (NIRS) is the dominant technology due to its long history of use in non-invasive monitoring of cerebral oxygenation and widespread adoption in clinical settings. Diffuse correlation spectroscopy (DCS) is the fastest-growing segment, thanks to its advanced capabilities for real-time measurements of cerebral blood flow and oxygenation, which has sparked increased interest and investment in this emerging technology.

Global Cerebral Somatic Oximeters Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Cerebral Somatic Oximeters Market are classified into North America, Europe, Asia Pacific, and Rest of the World. North America is the dominant region due to its advanced healthcare infrastructure, widespread adoption of medical technologies, and the presence of major medical device manufacturers. Asia Pacific is the fastest-growing region, owing to increased investments in healthcare infrastructure, rising prevalence of neurological disorders, and rising demand for advanced monitoring solutions in emerging economies such as China and India.

Key Players

The "Global Cerebral Somatic Oximeters Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Masimo, Medtronic, Edwards Lifesciences, ISS, Inc., Nonin Medical, Inc., Mespere LifeSciences, GE Healthcare.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Cerebral Somatic Oximeters Market: Recent Developments
• In April 2024, Philips Healthcare introduced a new line of cerebral somatic oximeters that incorporate cutting-edge technology for better patient monitoring and integration with existing healthcare systems.
• In May 2024, Nihon Kohden launched a portable cerebral oximeter with the goal of providing continuous monitoring in a variety of clinical settings, including emergency and neonatal care, while also improving mobility and ease of use.
• In March 2024, Nonin Medical introduced a new cerebral oximeter with upgraded sensor technology, promising improved accuracy and reliability in a variety of patient conditions, including critical and routine monitoring.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Cerebral Somatic Oximeters Market, By Product Type

• Non-invasive Cerebral Somatic Oximeters
• Invasive Cerebral Somatic Oximeters

5 Crebral Somatic Oximeters Market, By Application

• Neurocritical Care
• Anesthesiology
• Neonatal Care
• Cardiology
• Sports Medicine

6 Cerebral Somatic Oximeters Market, By Technology

• Near-infrared spectroscopy (NIRS)
• Photoacoustic spectroscopy (PAS)
• Diffuse correlation spectroscopy (DCS)

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Masimo
• Medtronic
• Edwards Lifesciences
• ISS Inc.
• Nonin Medical, Inc.
• Koninklijke Philips N.V.
• Mespere LifeSciences
• GE Healthcare

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References